Seattle Genetics Inc (SGEN)

neg -0.36
Today's Range: 31.00 - 31.85 | SGEN Avg Daily Volume: 1,340,800
Last Update: 01/30/15 - 3:59 PM EST
Volume: 828,526
YTD Performance: -1.96%
Open: $31.37
Previous Close: $31.50
52 Week Range: $30.05 - $55.99
Oustanding Shares: 123,891,580
Market Cap: 3,931,699,291
6-Month Chart
TheStreet Ratings Grade for SGEN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 5 5 5 4
Moderate Buy 0 0 0 0
Hold 3 3 3 2
Moderate Sell 1 1 1 1
Strong Sell 1 1 1 2
Mean Rec. 2.30 2.30 2.30 2.67
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -61.03
Price Earnings Comparisons:
SGEN Sector Avg. S&P 500
-61.03 0.00 25.58
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-10.69% -30.45% 60.63%
Revenue 27.70 1.51 0.35
Net Income 0.00 -0.06 0.00
EPS 0.00 -0.23 0.00
Earnings for SGEN:
Revenue 0.27B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $-0.26 $-0.19 $-0.66 $-0.50
Number of Analysts 9 1 10 10
High Estimate $-0.14 $-0.19 $-0.54 $-0.21
Low Estimate $-0.31 $-0.19 $-0.71 $-0.77
Prior Year $-0.13 $-0.13 $-0.51 $-0.66
Growth Rate (Year over Year) -97.44% -46.15% -29.61% 24.51%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Oct 31, 2014 | 7:01 AM EDT
SGEN was upgraded from Sell to Hold, Cantor Fitzgerald said. $35 price target. Company has improved pipeline visibility. 
Sep 30, 2014 | 7:42 AM EDT
SGEN was downgraded form Neutral to Underperform, Bank of America/Merrill Lynch said. $34 price target. Aethera data was not as positiv...
A HERO may still emerge.
Become more aggressive about the real valuations of companies.
The $193 level on the SPY will be key today.
Thursday's SPY trade plan will involve fading the edges,
You're looking at one.
May 06, 2014 | 7:19 AM EDT
SGEN was upgraded to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $40 price target. 
For these kinds of growth stocks, you have no choice but to wait.

Columnist Conversations

Ugly end to a challenging week as stocks post around three percent declines for the opening month of 2015. Oil...
I have scaled further into a TLT short - scaling all the way up to $138.35 this morning. And I have scaled int...
Market slightly down despite the boost Amazon (AMZN) is giving the NASDAQ. Biotech also continues to be a stro...
There are a number of interesting technical signals on the weekly and daily Berkshire Hathaway (BRK/B) charts....


Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.